Bristol-myers Squibb Co. Earnings

Bristol-myers Squibb Co.’s revenue fell -5.6% since last year same period to $11201Mn in the Q1 2025. On a quarterly growth basis, Bristol-myers Squibb Co. has generated -9.24% fall in its revenue since last 3-months.

Bristol-myers Squibb Co.’s net profit jumped 120.62% since last year same period to $2456Mn in the Q1 2025. On a quarterly growth basis, Bristol-myers Squibb Co. has generated 3311.11% jump in its net profits since last 3-months.

Bristol-myers Squibb Co.’s net profit margin jumped 121.84% since last year same period to 21.93% in the Q1 2025. On a quarterly growth basis, Bristol-myers Squibb Co. has generated 3658.59% jump in its net profit margins since last 3-months.

Bristol-myers Squibb Co.’s price-to-earnings ratio after this Q1 2025 earnings stands at 18.08.

Bristol-myers Squibb Co.’s earning per share (EPS) estimates for the current quarter stand at 1.71 - a 11.76% jump from last quarter’s estimates.

Bristol-myers Squibb Co.’s earning per share (EPS) estimates for the current year stand at 1.71.

Bristol-myers Squibb Co.’s earning per share (EPS) jumped 140.91% since last year same period to 1.8 in the Q1 2025. This indicates that the Bristol-myers Squibb Co. has generated 140.91% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Bristol-myers Squibb Co.’s return on assets (ROA) stands at 0.07.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Bristol-myers Squibb Co.’s return on equity (ROE) stands at 0.32.

Bristol-myers Squibb Co. declared 0.62 dividend per share during the earnings announcement for Q1 2025.